| L-Phenylalanine | CP2020 | EP11 | USP2023 | AJI92 | FCC11 |
| Assay | ≥98.5% | 98.5-101.0% | 98.5-101.5% | 99.0-100.5% | 98.5-101.5% |
| PH | 5.4-6.0 | / | 5.4-6.0 | 5.4-6.0 | 5.4-6.0 |
| Specific rotation[a]D20 | -33.0°–35.0° | -33.0°–35.5° | / | -33.5°–35.0° | -33.2°–35.2° |
| Specific rotation[a]D25 | / | / | -32.7°–34.7° | / | -32.7°–34.7° |
| Transmittance(T430) | ≥98.0% | / | / | ≥98.0% | / |
| Appearance of solution | / | clear & colorless ≤BY6 | / | / | / |
| Chloride(Cl) | ≤0.02% | ≤0.02% | ≤0.05% | ≤0.02% | / |
| Ammonium(NH4) | ≤0.02% | ≤0.02% | / | ≤0.02% | / |
| Sulfate(SO4) | ≤0.02% | ≤0.03% | ≤0.03% | ≤0.02% | / |
| Iron(Fe) | ≤10PPM | ≤10PPM | ≤30PPM | ≤10PPM | / |
| Heavy metals(Pb) | ≤10PPM | / | / | ≤10PPM | ≤5PPM |
| Arsenic | ≤1PPM | / | / | ≤1PPM | / |
| Other amino acids | ≤0.50% | / | Individual impurities≤0.5% Total impurities≤2.0% |
conform | / |
| Ninhydrin-positive substances | / | Each impurity≤ 0.2 % Total impurities≤ 0.5 % |
/ | / | / |
| Loss on drying | ≤0.20% | ≤0.50% | ≤0.30% | ≤0.20% | ≤0.20% |
| Residue on ignition | ≤0.10% | ≤0.10% | ≤0.40% | ≤0.10% | ≤0.10% |
| Endotoxin | <25EU/g | <25EU/g | <25EU/g | / | / |
| Total plate count | ≤ 1000 CFU/g | ≤ 1000 CFU/g | ≤ 1000 CFU/g | ≤ 1000 CFU/g | ≤ 1000 CFU/g |
| Moulds & Yeasts | ≤ 100 CFU/g | ≤ 100 CFU/g | ≤ 100 CFU/g | ≤ 100 CFU/g | ≤ 100 CFU/g |
Be the first to review “L-Phenylalanine” Cancel reply
Category: Other
Related products
-
Infliximab for Injection
Contact UsEfficacy and safety are equivalent to the original drug (Johnson & Johnson/Merck & Co.
-
-
Bevacizumab Injection
Contact UsBevacizumab, an anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF mAb)
-
Titanium Alloy Coil
Contact UsWe adhere to the business philosophy of “gathering all the steel in the world and achieving stainless quality”, sincerely looking forward to the joining and cooperation of domestic and foreign merchants, new and old users, and working together to create brilliance





Reviews
There are no reviews yet.